MedPath

Mesenteric Infiltration in Ovarian Cancer

Recruiting
Conditions
Ovary Cancer
Interventions
Diagnostic Test: Computed Tomography
Registration Number
NCT06331130
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
510
Inclusion Criteria
  1. Women with confirmed HGSOC wiht mesenteric involvment
  2. Age > 18 years
  3. FIGO STAGE IIIB-IV
  4. Primary diagnosis
  5. Signed informed consent
Exclusion Criteria
  1. Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer)
  2. Early stage disease (I and II stage)
  3. CT scan not available
  4. Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Prospective cohortComputed TomographyPatients affected by High Grade Seruous Ovarian Cancer with mesenteric infiltration confirmed by diagnostic laparoscopy
Retrospective cohortComputed TomographyPatients affected by High Grade Seruous Ovarian Cancer with mesenteric infiltration confirmed by diagnostic laparoscopy, from January 2021 to December 2023
Primary Outcome Measures
NameTimeMethod
Preoperative Artificial Intelligence assisted CT-based evaluation1 year

Preoperative Artificial Intelligence assisted CT-based prediction of patients with suboptimal debulking at surgery due to diffuse mesenteric disease or mesenteric retraction.

Secondary Outcome Measures
NameTimeMethod
Evaluation of the Radiologist Assessment of the CT1 year

Identification of mesenteric infiltration from CT images using Artificial Intelligence at a comparable performance with human/radiologist assessment.

Prediction of Platinum Resistance1 year

AI-assisted CT-based prediction of patients who will develop platinum resistance

Prediction of Progression Free Survival (PFS) and Overall Survival (OS)2 years

Prediction of Progression Free Survival (PFS) and Overall Survival (OS) with Artificial Intelligence

Trial Locations

Locations (1)

Advanced Radiology Center

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath